Furthermore, since oncogenic BRAF has been found to activate NFAT signaling in melanoma [24], and we found that CTHRC1 is expressed at high levels mainly in BRAF mutant melanoma cell lines, we examined the effect of BRAF inhibition on CTHRC1 expression. This evidence concerns the gene BRAF and melanoma.